SlideShare a Scribd company logo
1 of 23
Download to read offline
Emerging Labs in Healthcare
Spacesaver Corporation Learning Track December 2015
Spacesaver Learning Track:
Emerging Labs in Healthcare
Labs are Emerging – How Come?
Diagnostic and medical laboratories:
• Are vital to the healthcare sector providing healthcare
practitioners with information concerning the onset, severity and
cause of patients' ailments and illnesses.
• The aging population and the movement toward preventive care
have stimulated demand for industry services. For example, as
more elderly patients received preventive screening tests, many
required laboratory services to address irregular screening results.
Emerging Labs – How come?
• Demand for diagnostic and medical laboratory services is mainly influenced by
scientific advancements, which are yielding new and improved service
capabilities; an aging population, which increases demand for laboratory testing
and diagnostic imaging services; the extent to which physicians and their
patients appreciate the value that these services bring to health and wellness;
and the cost of services, which can be influenced by government program
reimbursement.
• The primary growth drivers for the Global Clinical Laboratory Services
Market are growing number of cancer, diabetes, tuberculosis, and other such
dangerous incidences and infections. As the patients have only grown in the
recent years, the market for clinical services has also grown and is expected
expand further. Analysts predict, the geriatric population in U.S. is expected to
grow by 20% in 2030. With such a huge leap, U.S. alone is expected to
contribute greatly to the global clinical laboratory services market.
What’s the Market?
• Specialized & General Lab space inside Hospitals & Clinics
What’s the Market?
• The Commercial Market growing in response to need. .
• The commercial medical and diagnostic laboratory industry in the
US consists of about 14,000 establishments (single-location
companies and units of multi-location companies) with combined
annual revenue of about $48 billion. Medical labs account for
about 60 percent of industry revenue; imaging centers account for
40 percent.
Who’s the Commercial Players?
• Major companies include (US Based):
• Alliance HealthCare Services
• LabCorp
• Quest Diagnostics
• RadNet
• The top four players (US) accounted for an estimated 28.7% of
industry revenue in 2015. However, market leaders Quest
Diagnostics and Laboratory Corp of America generate about
26.1% of total industry revenue.
Quest Diagnostics Inc. HQ Madison, NJ
• Market Share: 14.4%
• Quest Diagnostics Inc. (Quest) is the world’s leading provider of diagnostic
testing, information and services.
• Offers patients and physicians access to these services through its nationwide
network of laboratories and company-owned service centers.
• Founded in 1990, Quest employs about 42,000 workers and is headquartered in
Madison, NJ.
• Also operates 80 locations in the United States, where it coordinates
paramedical examinations related to life insurance applications.
• The company is recognized for developing new tests, technology and services,
which include personalized and targeted medicine.
•
“So What” for Spacesaver?
• Applications for storage of paraffin blocks, samples, supplies. . .
• Customer installs include:
• St Louis, MO – sold on GPO
Lab Corporation of America Holdings
(LabCorp)
• Market Share: 11.7%
• The company's services include:
• Routine and specialty testing, with a focus on infectious disease, oncology
and genetics.
• HQ Burlington, NC
• Services offered through a national network of 50 primary laboratories,
more than 1,800 patient service centers and a system of branches and
laboratories.
Trends in Labs. . .CLUSTERING
• Companies are increasingly moving into clusters located in urban
environments near universities, hospitals and related science and
technology companies.
• Helps attract and retain the best and brightest recruits, as the
new generation of scientists and researchers want to work and
play in stimulating environments populated by thought leaders.
• Clustering also creates the opportunity for interaction with other
centers of thinking; offers access to interdisciplinary collaboration
plus more diversity and quantity of data; and facilitates the goals
of translational medicine.
CLUSTERING. . .Impact on Space. . .
• Real estate costs go up.
• Companies must use their lab space more efficiently.
• The idea that every person has a designated desk or lab bench seat is changing. This also
is true of academic lab settings.
• Flexible Labs:
• At the Jackson Laboratory for Genomic Medicine, the current lab space represents a
50/50 ratio of wet to dry space, with “flex” lab space in between the wet modules
to allow for growth of either the wet or dry programs as needed.
• Collaboration spaces are essential in today’s labs. Small discussion/conference areas are
placed in immediate proximity to lab areas, creating ease of motion from one zone to
another, thereby fostering spontaneous collaboration.
• Writing surfaces are important within these spaces, and interior glass windows often
function as writing surfaces. (GE Moveable Walls?) There is also a trend away from
programmed “huddle spaces” along corridors and toward more general-purpose
amenities like coffee bars.
Titles of Decision Makers
• Capital Project Teams
• Project Managers
• Research Program Directors
• Facility Managers
• Facility Engineers
• Capital Planners Scientists
• Faculty
• Research Operations Managers
Photo Tour
Emerging Trends in Labs. Spacesaver Learning Track
Cardiac Cath Lab
Memorial Hospital of Carbondale
Cardiac Cath Lab
Memorial Hospital of Carbondale
Cardiac Cath Lab
Memorial Hospital of Carbondale
Memorial Hosp of Carbondale -Main Cath Lab
BJC – Lab Slides
BJC- Lab Slide Storage -Paraffin Block Storage
BJC – Lab Sample Storage
St. Luke's -Pathology Lab Storage

More Related Content

What's hot

The Evolution of Drug Development and Market Access via Connected Data-Driven...
The Evolution of Drug Development and Market Access via Connected Data-Driven...The Evolution of Drug Development and Market Access via Connected Data-Driven...
The Evolution of Drug Development and Market Access via Connected Data-Driven...PAREXEL International
 
Future of RWE Digital Pharma West presentation
Future of RWE Digital Pharma West presentationFuture of RWE Digital Pharma West presentation
Future of RWE Digital Pharma West presentationSaama
 
Next Generation Digital Trials - Introduction to a changing landscape
Next Generation Digital Trials - Introduction to a changing landscape Next Generation Digital Trials - Introduction to a changing landscape
Next Generation Digital Trials - Introduction to a changing landscape DayOne
 
Using MCDA for HTA, Opportunities, Challenges and Possible Ways Forward
Using MCDA for HTA, Opportunities, Challenges and Possible Ways ForwardUsing MCDA for HTA, Opportunities, Challenges and Possible Ways Forward
Using MCDA for HTA, Opportunities, Challenges and Possible Ways ForwardOffice of Health Economics
 
Patient Centricity: EHR Pillars to Patient Centricity
Patient Centricity: EHR Pillars to Patient CentricityPatient Centricity: EHR Pillars to Patient Centricity
Patient Centricity: EHR Pillars to Patient CentricityDayOne
 
Pistoia alliance debates analytics 15-09-2015 16.00
Pistoia alliance debates   analytics 15-09-2015 16.00Pistoia alliance debates   analytics 15-09-2015 16.00
Pistoia alliance debates analytics 15-09-2015 16.00Pistoia Alliance
 
Solving the operational challenges of oncology clinical trials
Solving the operational challenges of oncology clinical trialsSolving the operational challenges of oncology clinical trials
Solving the operational challenges of oncology clinical trialsRoberto Lara
 
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...Office of Health Economics
 
Key Strategies to Survive in Today\’s Changing World of Oncology Clinical Trials
Key Strategies to Survive in Today\’s Changing World of Oncology Clinical TrialsKey Strategies to Survive in Today\’s Changing World of Oncology Clinical Trials
Key Strategies to Survive in Today\’s Changing World of Oncology Clinical TrialsRoberto Lara
 
What Your CRO Doesn't Know Could Hurt You
What Your CRO Doesn't Know Could Hurt YouWhat Your CRO Doesn't Know Could Hurt You
What Your CRO Doesn't Know Could Hurt YouRoberto Lara
 
Ksr Clinical Introduction 2009 1
Ksr Clinical Introduction  2009 1Ksr Clinical Introduction  2009 1
Ksr Clinical Introduction 2009 1DianaFleszar
 
Ksr Clinical Introduction 2009 1
Ksr Clinical Introduction  2009 1Ksr Clinical Introduction  2009 1
Ksr Clinical Introduction 2009 1brianwilson030999
 
Cortellis for CTI Message Platform
Cortellis for CTI Message PlatformCortellis for CTI Message Platform
Cortellis for CTI Message PlatformMichael Passanante
 
DawnRunkel_resumenew
DawnRunkel_resumenewDawnRunkel_resumenew
DawnRunkel_resumenewDawn Runkel
 
Tools to Drive Enrollment OCT Arena-Boston-2015
Tools to Drive Enrollment OCT Arena-Boston-2015Tools to Drive Enrollment OCT Arena-Boston-2015
Tools to Drive Enrollment OCT Arena-Boston-2015Dan Diaz
 

What's hot (20)

The Evolution of Drug Development and Market Access via Connected Data-Driven...
The Evolution of Drug Development and Market Access via Connected Data-Driven...The Evolution of Drug Development and Market Access via Connected Data-Driven...
The Evolution of Drug Development and Market Access via Connected Data-Driven...
 
Future of RWE Digital Pharma West presentation
Future of RWE Digital Pharma West presentationFuture of RWE Digital Pharma West presentation
Future of RWE Digital Pharma West presentation
 
Next Generation Digital Trials - Introduction to a changing landscape
Next Generation Digital Trials - Introduction to a changing landscape Next Generation Digital Trials - Introduction to a changing landscape
Next Generation Digital Trials - Introduction to a changing landscape
 
Cortellis for CTI sell sheet
Cortellis for CTI sell sheetCortellis for CTI sell sheet
Cortellis for CTI sell sheet
 
CTI Landing Page
CTI Landing PageCTI Landing Page
CTI Landing Page
 
Using MCDA for HTA, Opportunities, Challenges and Possible Ways Forward
Using MCDA for HTA, Opportunities, Challenges and Possible Ways ForwardUsing MCDA for HTA, Opportunities, Challenges and Possible Ways Forward
Using MCDA for HTA, Opportunities, Challenges and Possible Ways Forward
 
Patient Centricity: EHR Pillars to Patient Centricity
Patient Centricity: EHR Pillars to Patient CentricityPatient Centricity: EHR Pillars to Patient Centricity
Patient Centricity: EHR Pillars to Patient Centricity
 
Pistoia alliance debates analytics 15-09-2015 16.00
Pistoia alliance debates   analytics 15-09-2015 16.00Pistoia alliance debates   analytics 15-09-2015 16.00
Pistoia alliance debates analytics 15-09-2015 16.00
 
AnovusPresentation 2015
AnovusPresentation 2015AnovusPresentation 2015
AnovusPresentation 2015
 
Solving the operational challenges of oncology clinical trials
Solving the operational challenges of oncology clinical trialsSolving the operational challenges of oncology clinical trials
Solving the operational challenges of oncology clinical trials
 
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potentia...
 
Key Strategies to Survive in Today\’s Changing World of Oncology Clinical Trials
Key Strategies to Survive in Today\’s Changing World of Oncology Clinical TrialsKey Strategies to Survive in Today\’s Changing World of Oncology Clinical Trials
Key Strategies to Survive in Today\’s Changing World of Oncology Clinical Trials
 
Competitive battlecard
Competitive battlecard Competitive battlecard
Competitive battlecard
 
What Your CRO Doesn't Know Could Hurt You
What Your CRO Doesn't Know Could Hurt YouWhat Your CRO Doesn't Know Could Hurt You
What Your CRO Doesn't Know Could Hurt You
 
Ksr Clinical Introduction 2009 1
Ksr Clinical Introduction  2009 1Ksr Clinical Introduction  2009 1
Ksr Clinical Introduction 2009 1
 
Ksr Clinical Introduction 2009 1
Ksr Clinical Introduction  2009 1Ksr Clinical Introduction  2009 1
Ksr Clinical Introduction 2009 1
 
Cortellis for CTI Message Platform
Cortellis for CTI Message PlatformCortellis for CTI Message Platform
Cortellis for CTI Message Platform
 
DawnRunkel_resumenew
DawnRunkel_resumenewDawnRunkel_resumenew
DawnRunkel_resumenew
 
CTI Ad
CTI AdCTI Ad
CTI Ad
 
Tools to Drive Enrollment OCT Arena-Boston-2015
Tools to Drive Enrollment OCT Arena-Boston-2015Tools to Drive Enrollment OCT Arena-Boston-2015
Tools to Drive Enrollment OCT Arena-Boston-2015
 

Viewers also liked

quest diagnostics 6_25Jefferies6_26_07
quest diagnostics 6_25Jefferies6_26_07quest diagnostics 6_25Jefferies6_26_07
quest diagnostics 6_25Jefferies6_26_07finance34
 
agilent_2000_ar
agilent_2000_aragilent_2000_ar
agilent_2000_arfinance38
 
SP, Workforce Singapore and Agilent Technologies Lean Enterprise Development ...
SP, Workforce Singapore and Agilent Technologies Lean Enterprise Development ...SP, Workforce Singapore and Agilent Technologies Lean Enterprise Development ...
SP, Workforce Singapore and Agilent Technologies Lean Enterprise Development ...Serene Leong
 
Managing Services Spend ...
Managing Services Spend ...Managing Services Spend ...
Managing Services Spend ...Peter Woon
 
Agilent Technologies Corporate Overview
Agilent Technologies Corporate OverviewAgilent Technologies Corporate Overview
Agilent Technologies Corporate Overviewrajsodhi
 
Thermo Fisher Scientific Kanban Project Poster_AYA
Thermo Fisher Scientific Kanban Project Poster_AYAThermo Fisher Scientific Kanban Project Poster_AYA
Thermo Fisher Scientific Kanban Project Poster_AYAAna (Anya) Soloviov
 
Managing the Cold Chain to Minimize Pre-Analytical Variability
Managing the Cold Chain to Minimize Pre-Analytical VariabilityManaging the Cold Chain to Minimize Pre-Analytical Variability
Managing the Cold Chain to Minimize Pre-Analytical VariabilityThermo Fisher Scientific
 
Cell Biology Antibodies
Cell Biology AntibodiesCell Biology Antibodies
Cell Biology AntibodiesElabscience
 
Thermofisher scientific ltd- organisational behaviour
Thermofisher scientific ltd- organisational behaviourThermofisher scientific ltd- organisational behaviour
Thermofisher scientific ltd- organisational behaviourDhruv Chakravarty
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIfinance40
 
GovTech Market Snapshot
GovTech Market SnapshotGovTech Market Snapshot
GovTech Market SnapshotDustin Haisler
 

Viewers also liked (18)

Salmonella Fact Sheet
Salmonella Fact SheetSalmonella Fact Sheet
Salmonella Fact Sheet
 
quest diagnostics 6_25Jefferies6_26_07
quest diagnostics 6_25Jefferies6_26_07quest diagnostics 6_25Jefferies6_26_07
quest diagnostics 6_25Jefferies6_26_07
 
agilent_2000_ar
agilent_2000_aragilent_2000_ar
agilent_2000_ar
 
NGNM Company Overview Presentation
NGNM Company Overview PresentationNGNM Company Overview Presentation
NGNM Company Overview Presentation
 
usg AR_2000
usg AR_2000usg AR_2000
usg AR_2000
 
Vibrio Infographic
Vibrio InfographicVibrio Infographic
Vibrio Infographic
 
SP, Workforce Singapore and Agilent Technologies Lean Enterprise Development ...
SP, Workforce Singapore and Agilent Technologies Lean Enterprise Development ...SP, Workforce Singapore and Agilent Technologies Lean Enterprise Development ...
SP, Workforce Singapore and Agilent Technologies Lean Enterprise Development ...
 
2016 06 08 neo company overview presentation
2016 06 08   neo company overview presentation2016 06 08   neo company overview presentation
2016 06 08 neo company overview presentation
 
Managing Services Spend ...
Managing Services Spend ...Managing Services Spend ...
Managing Services Spend ...
 
Agilent Technologies Corporate Overview
Agilent Technologies Corporate OverviewAgilent Technologies Corporate Overview
Agilent Technologies Corporate Overview
 
Mycoplasma Infographic
Mycoplasma Infographic Mycoplasma Infographic
Mycoplasma Infographic
 
We've moved!
We've moved!We've moved!
We've moved!
 
Thermo Fisher Scientific Kanban Project Poster_AYA
Thermo Fisher Scientific Kanban Project Poster_AYAThermo Fisher Scientific Kanban Project Poster_AYA
Thermo Fisher Scientific Kanban Project Poster_AYA
 
Managing the Cold Chain to Minimize Pre-Analytical Variability
Managing the Cold Chain to Minimize Pre-Analytical VariabilityManaging the Cold Chain to Minimize Pre-Analytical Variability
Managing the Cold Chain to Minimize Pre-Analytical Variability
 
Cell Biology Antibodies
Cell Biology AntibodiesCell Biology Antibodies
Cell Biology Antibodies
 
Thermofisher scientific ltd- organisational behaviour
Thermofisher scientific ltd- organisational behaviourThermofisher scientific ltd- organisational behaviour
Thermofisher scientific ltd- organisational behaviour
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
 
GovTech Market Snapshot
GovTech Market SnapshotGovTech Market Snapshot
GovTech Market Snapshot
 

Similar to Emerging Labs in Healthcare

Integrate RWE into clinical development
Integrate RWE into clinical developmentIntegrate RWE into clinical development
Integrate RWE into clinical developmentIMSHealthRWES
 
성공하는 디지털 헬스케어 스타트업을 위한 8가지 조언
성공하는 디지털 헬스케어 스타트업을 위한 8가지 조언성공하는 디지털 헬스케어 스타트업을 위한 8가지 조언
성공하는 디지털 헬스케어 스타트업을 위한 8가지 조언Yoon Sup Choi
 
Clinical genomics spx
Clinical genomics   spxClinical genomics   spx
Clinical genomics spxDiane McKenna
 
Customized Oncology Development Solutions: Clinical Trials Designed Around You®
Customized Oncology Development Solutions: Clinical Trials Designed Around You®Customized Oncology Development Solutions: Clinical Trials Designed Around You®
Customized Oncology Development Solutions: Clinical Trials Designed Around You®Covance
 
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...MedStatix, LLC
 
Late Phase Presentation
Late Phase PresentationLate Phase Presentation
Late Phase PresentationDavid Selkirk
 
Delivering real world evidence to demonstrate product safety and value
Delivering real world evidence to demonstrate product safety and valueDelivering real world evidence to demonstrate product safety and value
Delivering real world evidence to demonstrate product safety and valueKishan Patel, MBA
 
Patient engagement in clinical trials
Patient engagement in clinical trials Patient engagement in clinical trials
Patient engagement in clinical trials Martin Kelly
 
Connected Health & Me - Matic Meglic - Nov 24th 2014
Connected Health & Me - Matic Meglic - Nov 24th 2014Connected Health & Me - Matic Meglic - Nov 24th 2014
Connected Health & Me - Matic Meglic - Nov 24th 2014ipposi
 
Diagnostics Market Disruption HIDA final
Diagnostics Market Disruption HIDA finalDiagnostics Market Disruption HIDA final
Diagnostics Market Disruption HIDA finalHidee Cyd
 
Service Innovation in Healthcare
Service Innovation in Healthcare Service Innovation in Healthcare
Service Innovation in Healthcare Spring Wedlund
 
Real World Late Phase The right approach for the right question
Real World Late Phase The right approach for the right questionReal World Late Phase The right approach for the right question
Real World Late Phase The right approach for the right questionSatish Kumar
 
Pharma IQ - Clinical Series 2011
Pharma IQ - Clinical Series 2011Pharma IQ - Clinical Series 2011
Pharma IQ - Clinical Series 2011Pharma IQ
 
Pcori health 2.0 challenge with screenshots_patients_likeme_041513
Pcori health 2.0 challenge with screenshots_patients_likeme_041513Pcori health 2.0 challenge with screenshots_patients_likeme_041513
Pcori health 2.0 challenge with screenshots_patients_likeme_041513Sally Okun
 
Generating Quality Data through Collaborative Research with an ACO
Generating Quality Data through Collaborative Research with an ACOGenerating Quality Data through Collaborative Research with an ACO
Generating Quality Data through Collaborative Research with an ACOTodd Berner MD
 
ReSuture Pitch Deck Demo Day PDF
ReSuture Pitch Deck Demo Day PDF ReSuture Pitch Deck Demo Day PDF
ReSuture Pitch Deck Demo Day PDF Hannah Eherenfeldt
 
EuroBioForum 2013 - Day 2 | Mark Poznansky
 EuroBioForum 2013 - Day 2 | Mark Poznansky EuroBioForum 2013 - Day 2 | Mark Poznansky
EuroBioForum 2013 - Day 2 | Mark PoznanskyEuroBioForum
 
Accelerating Clinical Trials trough Multi-Stakeholder Collaborations
Accelerating Clinical Trials trough Multi-Stakeholder CollaborationsAccelerating Clinical Trials trough Multi-Stakeholder Collaborations
Accelerating Clinical Trials trough Multi-Stakeholder CollaborationsWorldCongress
 
Nurse scientists as knowledge brokers
Nurse scientists as knowledge brokersNurse scientists as knowledge brokers
Nurse scientists as knowledge brokersLatha Venkatesan
 
College Writing II Synthesis Essay Assignment Summer Semester 2017.docx
College Writing II Synthesis Essay Assignment Summer Semester 2017.docxCollege Writing II Synthesis Essay Assignment Summer Semester 2017.docx
College Writing II Synthesis Essay Assignment Summer Semester 2017.docxclarebernice
 

Similar to Emerging Labs in Healthcare (20)

Integrate RWE into clinical development
Integrate RWE into clinical developmentIntegrate RWE into clinical development
Integrate RWE into clinical development
 
성공하는 디지털 헬스케어 스타트업을 위한 8가지 조언
성공하는 디지털 헬스케어 스타트업을 위한 8가지 조언성공하는 디지털 헬스케어 스타트업을 위한 8가지 조언
성공하는 디지털 헬스케어 스타트업을 위한 8가지 조언
 
Clinical genomics spx
Clinical genomics   spxClinical genomics   spx
Clinical genomics spx
 
Customized Oncology Development Solutions: Clinical Trials Designed Around You®
Customized Oncology Development Solutions: Clinical Trials Designed Around You®Customized Oncology Development Solutions: Clinical Trials Designed Around You®
Customized Oncology Development Solutions: Clinical Trials Designed Around You®
 
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...
A Leading Patient Experience Survey Platform by MedStatix - White Labeled for...
 
Late Phase Presentation
Late Phase PresentationLate Phase Presentation
Late Phase Presentation
 
Delivering real world evidence to demonstrate product safety and value
Delivering real world evidence to demonstrate product safety and valueDelivering real world evidence to demonstrate product safety and value
Delivering real world evidence to demonstrate product safety and value
 
Patient engagement in clinical trials
Patient engagement in clinical trials Patient engagement in clinical trials
Patient engagement in clinical trials
 
Connected Health & Me - Matic Meglic - Nov 24th 2014
Connected Health & Me - Matic Meglic - Nov 24th 2014Connected Health & Me - Matic Meglic - Nov 24th 2014
Connected Health & Me - Matic Meglic - Nov 24th 2014
 
Diagnostics Market Disruption HIDA final
Diagnostics Market Disruption HIDA finalDiagnostics Market Disruption HIDA final
Diagnostics Market Disruption HIDA final
 
Service Innovation in Healthcare
Service Innovation in Healthcare Service Innovation in Healthcare
Service Innovation in Healthcare
 
Real World Late Phase The right approach for the right question
Real World Late Phase The right approach for the right questionReal World Late Phase The right approach for the right question
Real World Late Phase The right approach for the right question
 
Pharma IQ - Clinical Series 2011
Pharma IQ - Clinical Series 2011Pharma IQ - Clinical Series 2011
Pharma IQ - Clinical Series 2011
 
Pcori health 2.0 challenge with screenshots_patients_likeme_041513
Pcori health 2.0 challenge with screenshots_patients_likeme_041513Pcori health 2.0 challenge with screenshots_patients_likeme_041513
Pcori health 2.0 challenge with screenshots_patients_likeme_041513
 
Generating Quality Data through Collaborative Research with an ACO
Generating Quality Data through Collaborative Research with an ACOGenerating Quality Data through Collaborative Research with an ACO
Generating Quality Data through Collaborative Research with an ACO
 
ReSuture Pitch Deck Demo Day PDF
ReSuture Pitch Deck Demo Day PDF ReSuture Pitch Deck Demo Day PDF
ReSuture Pitch Deck Demo Day PDF
 
EuroBioForum 2013 - Day 2 | Mark Poznansky
 EuroBioForum 2013 - Day 2 | Mark Poznansky EuroBioForum 2013 - Day 2 | Mark Poznansky
EuroBioForum 2013 - Day 2 | Mark Poznansky
 
Accelerating Clinical Trials trough Multi-Stakeholder Collaborations
Accelerating Clinical Trials trough Multi-Stakeholder CollaborationsAccelerating Clinical Trials trough Multi-Stakeholder Collaborations
Accelerating Clinical Trials trough Multi-Stakeholder Collaborations
 
Nurse scientists as knowledge brokers
Nurse scientists as knowledge brokersNurse scientists as knowledge brokers
Nurse scientists as knowledge brokers
 
College Writing II Synthesis Essay Assignment Summer Semester 2017.docx
College Writing II Synthesis Essay Assignment Summer Semester 2017.docxCollege Writing II Synthesis Essay Assignment Summer Semester 2017.docx
College Writing II Synthesis Essay Assignment Summer Semester 2017.docx
 

Emerging Labs in Healthcare

  • 1. Emerging Labs in Healthcare Spacesaver Corporation Learning Track December 2015
  • 3. Labs are Emerging – How Come? Diagnostic and medical laboratories: • Are vital to the healthcare sector providing healthcare practitioners with information concerning the onset, severity and cause of patients' ailments and illnesses. • The aging population and the movement toward preventive care have stimulated demand for industry services. For example, as more elderly patients received preventive screening tests, many required laboratory services to address irregular screening results.
  • 4. Emerging Labs – How come? • Demand for diagnostic and medical laboratory services is mainly influenced by scientific advancements, which are yielding new and improved service capabilities; an aging population, which increases demand for laboratory testing and diagnostic imaging services; the extent to which physicians and their patients appreciate the value that these services bring to health and wellness; and the cost of services, which can be influenced by government program reimbursement. • The primary growth drivers for the Global Clinical Laboratory Services Market are growing number of cancer, diabetes, tuberculosis, and other such dangerous incidences and infections. As the patients have only grown in the recent years, the market for clinical services has also grown and is expected expand further. Analysts predict, the geriatric population in U.S. is expected to grow by 20% in 2030. With such a huge leap, U.S. alone is expected to contribute greatly to the global clinical laboratory services market.
  • 5. What’s the Market? • Specialized & General Lab space inside Hospitals & Clinics
  • 6. What’s the Market? • The Commercial Market growing in response to need. . • The commercial medical and diagnostic laboratory industry in the US consists of about 14,000 establishments (single-location companies and units of multi-location companies) with combined annual revenue of about $48 billion. Medical labs account for about 60 percent of industry revenue; imaging centers account for 40 percent.
  • 7. Who’s the Commercial Players? • Major companies include (US Based): • Alliance HealthCare Services • LabCorp • Quest Diagnostics • RadNet • The top four players (US) accounted for an estimated 28.7% of industry revenue in 2015. However, market leaders Quest Diagnostics and Laboratory Corp of America generate about 26.1% of total industry revenue.
  • 8. Quest Diagnostics Inc. HQ Madison, NJ • Market Share: 14.4% • Quest Diagnostics Inc. (Quest) is the world’s leading provider of diagnostic testing, information and services. • Offers patients and physicians access to these services through its nationwide network of laboratories and company-owned service centers. • Founded in 1990, Quest employs about 42,000 workers and is headquartered in Madison, NJ. • Also operates 80 locations in the United States, where it coordinates paramedical examinations related to life insurance applications. • The company is recognized for developing new tests, technology and services, which include personalized and targeted medicine. •
  • 9. “So What” for Spacesaver? • Applications for storage of paraffin blocks, samples, supplies. . . • Customer installs include: • St Louis, MO – sold on GPO
  • 10. Lab Corporation of America Holdings (LabCorp) • Market Share: 11.7% • The company's services include: • Routine and specialty testing, with a focus on infectious disease, oncology and genetics. • HQ Burlington, NC • Services offered through a national network of 50 primary laboratories, more than 1,800 patient service centers and a system of branches and laboratories.
  • 11. Trends in Labs. . .CLUSTERING • Companies are increasingly moving into clusters located in urban environments near universities, hospitals and related science and technology companies. • Helps attract and retain the best and brightest recruits, as the new generation of scientists and researchers want to work and play in stimulating environments populated by thought leaders. • Clustering also creates the opportunity for interaction with other centers of thinking; offers access to interdisciplinary collaboration plus more diversity and quantity of data; and facilitates the goals of translational medicine.
  • 12. CLUSTERING. . .Impact on Space. . . • Real estate costs go up. • Companies must use their lab space more efficiently. • The idea that every person has a designated desk or lab bench seat is changing. This also is true of academic lab settings. • Flexible Labs: • At the Jackson Laboratory for Genomic Medicine, the current lab space represents a 50/50 ratio of wet to dry space, with “flex” lab space in between the wet modules to allow for growth of either the wet or dry programs as needed. • Collaboration spaces are essential in today’s labs. Small discussion/conference areas are placed in immediate proximity to lab areas, creating ease of motion from one zone to another, thereby fostering spontaneous collaboration. • Writing surfaces are important within these spaces, and interior glass windows often function as writing surfaces. (GE Moveable Walls?) There is also a trend away from programmed “huddle spaces” along corridors and toward more general-purpose amenities like coffee bars.
  • 13. Titles of Decision Makers • Capital Project Teams • Project Managers • Research Program Directors • Facility Managers • Facility Engineers • Capital Planners Scientists • Faculty • Research Operations Managers
  • 14. Photo Tour Emerging Trends in Labs. Spacesaver Learning Track
  • 15. Cardiac Cath Lab Memorial Hospital of Carbondale
  • 16. Cardiac Cath Lab Memorial Hospital of Carbondale
  • 17. Cardiac Cath Lab Memorial Hospital of Carbondale
  • 18.
  • 19. Memorial Hosp of Carbondale -Main Cath Lab
  • 20. BJC – Lab Slides
  • 21. BJC- Lab Slide Storage -Paraffin Block Storage
  • 22. BJC – Lab Sample Storage
  • 23. St. Luke's -Pathology Lab Storage